Publications by authors named "Jamile Shammo"

Claim this Profile
A
A prospective study of serum folate levels in patients with solid tumors treated with olaparib.
Jamile Shammo, Laura Owczarzak, Nicole K Yun, Lois Winkelman, Sanjib Basu

Oncologist· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved Iron Overload with Pegcetacoplan in Eculizumab-Experienced Patients with Paroxysmal Nocturnal Hemoglobinuria.
Jamile Shammo, Peter Hillmen, Peter Blandino, Vijay Abilash, David J Kuter

Int J Mol Sci· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and safety of danicopan as add-on therapy to ravulizumab or eculizumab in PNH with significant EVH.
Austin Kulasekararaj, Morag Griffin, Caroline Piatek, Jamile Shammo, Jun-Ichi Nishimura

Blood· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert consensus on the management of pharmacodynamic breakthrough-hemolysis in treated paroxysmal nocturnal hemoglobinuria.
David Dingli, Carlos De Castro Iii, Jamie Koprivnikar, Austin Kulasekararaj, Jaroslaw Maciejewski, Jamile Shammo

Hematology· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current landscape of paroxysmal nocturnal hemoglobinuria in the era of complement inhibitors and regulators.
Julia J Shi, Yusuf M Ozcan, Carlos I Ayala Santos, Hetalkumari Patel, Jamile Shammo

Ther Adv Hematol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paroxysmal nocturnal hemoglobinuria: Review of the patient experience and treatment landscape.
Anem Waheed, Jamile Shammo, David Dingli

Blood Rev· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver fibrosis and its response to avapritinib in 2 patients with systemic mastocytosis.
Karla Cavazos, Sheila Eswaran, Cathleen Maidlow, Fatma Keklik Karadag, Ramazan Idilman, Jamile Shammo

Blood Adv· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anagrelide for platelet-directed cytoreduction in polycythemia vera: Insights into utility and safety outcomes from a large multi-center database.
Noa Rippel, Douglas Tremblay, Nicole Zubizarreta, Nikolai Podoltsev, Jason Gotlib, Jamile M Shammo

Leuk Res· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low Rate of Clinically Evident Extravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with a Complement C5 Inhibitor: Results from a Large, Multicenter, US Real-World Study.
Jamile Shammo, Ajeet Gajra, Yogesh Patel, Ioannis Tomazos, Jonathan Kish

J Blood Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European LeukemiaNet Response Predicts Disease Progression but Not Thrombosis in Polycythemia Vera.
Douglas Tremblay, Andrew Srisuwananukorn, Lukas Ronner, Nikolai Podoltsev, Jason Gotlib, Jamile M Shammo

Hemasphere· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transfusion Independence Achieved with Combination Fedratinib and Luspatercept in an Elderly Man with Heavily Pretreated Intermediate-2 Risk Primary Myelofibrosis.
Nicole K Yun, Taha Alrifai, Ira J Miller, Jamile M Shammo

Case Rep Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ruxolitinib discontinuation in polycythemia vera: Patient characteristics, outcomes, and salvage strategies from a large multi-institutional database.
Douglas Tremblay, Lukas Ronner, Nikolai Podoltsev, Jason Gotlib, Mark Heaney, Jamile M Shammo

Leuk Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel patient-reported outcome instrument assessing the symptoms of paroxysmal nocturnal hemoglobinuria, the PNH-SQ.
R Paola Daly, Jessica J Jalbert, Shannon Keith, Tara Symonds, Jamile Shammo

J Patient Rep Outcomes· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The May-Hegglin anomaly: a rare cause of a common complaint.
Priyanka Reddy, Revathi Kollipara, Jamile M Shammo, Jerome Loew

BMJ Case Rep· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paroxysmal nocturnal hemoglobinuria: patient journey and burden of disease.
Meryem Bektas, Catherine Copley-Merriman, Shahnaz Khan, Sujata P Sarda, Jamile M Shammo

J Manag Care Spec Pharm· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paroxysmal nocturnal hemoglobinuria: role of the complement system, pathogenesis, and pathophysiology.
Meryem Bektas, Catherine Copley-Merriman, Shahnaz Khan, Sujata P Sarda, Jamile M Shammo

J Manag Care Spec Pharm· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paroxysmal nocturnal hemoglobinuria: current treatments and unmet needs.
Meryem Bektas, Catherine Copley-Merriman, Shahnaz Khan, Sujata P Sarda, Jamile M Shammo

J Manag Care Spec Pharm· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significance of isolated deletion (20q) in donor cells after allogeneic hematopoietic cell transplantation.
Sunita Nathan, Sushma Bharadwaj, Kristy Luke, Laura Kalas, Deborah A Katz, Jamile Shammo

Leuk Lymphoma· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry.
Hubert Schrezenmeier, Alexander Röth, David J Araten, Yuzuru Kanakura, Loree Larratt, Jamile M Shammo

Ann Hematol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis.
Lukas Ronner, Nikolai Podoltsev, Jason Gotlib, Mark L Heaney, Andrew T Kuykendall, Jamile Shammo

Blood· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib-Induced Severe Folate Deficiency in a Patient With Advanced Ovarian Cancer.
Jamile M Shammo, Lydia Usha, Kristin J Richardson, Elizabeth Elliott, Summer Dewdney

J Oncol Pract· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical consequences of iron overload in patients with myelodysplastic syndromes: the case for iron chelation therapy.
Jamile M Shammo, Rami S Komrokji

Expert Rev Hematol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia.
Jason X Cheng, Li Chen, Yuan Li, Adam Cloe, Ming Yue, Jamile M Shammo

Nat Commun· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia.
Jason X Cheng, Li Chen, Yuan Li, Adam Cloe, Ming Yue, Jamile M Shammo

Nat Commun· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hereditary Hemochromatosis Manifesting After Treatment of Paroxysmal Nocturnal Hemoglobinuria With Eculizumab.
Elizabeth Elliott, Salman Waheed, Sahr Syed, Sheila Eswaran, Stephanie Gregory, Jamile Shammo

Clin Lymphoma Myeloma Leuk· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis